Safety of Ciprofloxacin in Children With Cystic Fibrosis

Abstract

Get full access to this article

View all access options for this article.

References

Stutman H. Summary of a workshop on ciprofloxacin use in patients with cystic fibrosis . Pediatr Infect Dis. 1987;6:932-935.

Strandvik B. , Hjelte L. , Lindblad A. , et al. Comparison of efficacy and tolerance of intravenously and orally administered ciprofloxacin in cystic fibrosis patients with acute exacerbations of lung infection. Scand J Infect Dis. 1989;60 (suppl):84-88.

Rubio T. Ciprofloxacin in the treatment of Pseudomonas infections in children with cystic fibrosis. Diag Microbiol Infect Dis. 1990;13:153-155.

Cipro. West Haven, CT: Miles Laboratories ; 1989. Product monograph.

Alfaham M. , Holt M. , Goodchild M. Arthropathy in a patient with cystic fibrosis taking ciprofloxacin . BMJ. 1987;295:699.

Phillips B. , David T. Pathogenesis and management of arthropathy in cystic fibrosis. J Royal Soc Med. 1986;79(suppl 12):44-60.

Schaad U. , Stoupis C. , Wedgwood J. , et al. Clinical radiologic and magnetic resonance monitoring for skeletal toxicity in paediatric patients with cystic fibrosis receiving a three-month course of ciprofloxacin. Pediatr Infect Dis. 1991;10: 723-729.

Miller M. , Gaido F. , Rourk M. , Spock A. Anaphylactoid reactions to ciprofloxacin in cystic fibrosis patients . Pediatr Infect Dis J. 1991;10:164-165.